Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Vercise™ DBS Dystonia Prospective Study

NCT: NCT02686125 · RECRUITING

NCT IDNCT02686125
StatusRECRUITING
Start Date2016-03-07
Completion2030-12

Brief Summary

To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.

Frequently Asked Questions

What is Vercise™ DBS Dystonia Prospective Study?

Vercise™ DBS Dystonia Prospective Study is a clinical trial registered under NCT02686125. Current status: RECRUITING.

What is the status of NCT02686125?

The current status of NCT02686125 (Vercise™ DBS Dystonia Prospective Study) is: RECRUITING.

When did Vercise™ DBS Dystonia Prospective Study start?

Vercise™ DBS Dystonia Prospective Study started on 2016-03-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑